Clinical Trial

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-11-16; most recent amendment 2025-11-06.
Trial Details
NCT Number NCT06144164
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Lymphedema, Lymphedema Arm, Lymphedema of Upper Arm, Breast Cancer, Breast Carcinoma, Female Breast Cancer
Enrollment 285 participants
Start Date 2023-11-16
Primary Completion 2030-03-16 (estimated)
Study Completion 2030-03-16 (estimated)
Updated on ClinicalTrials.gov 2025-11-10